BCMA CAR-T Cell Therapy in High-risk NDMM Patients With Positive MRD After First-line ASCT
Clinical trial NCT05846737 · WITHDRAWN
Trial details
- NCT number
- NCT05846737
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-29
- Primary completion
- 2025-05-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.